Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 11/20 | 0.57 |
| ▸ | CYBB | P04839 | 2/20 | 0.57 |
| ▸ | NOX3 | Q9HBY0 | 2/20 | 0.57 |
| ▸ | NOX4 | Q9NPH5 | 2/20 | 0.57 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | GAA | P10253 | 5/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | CNR1 | P21554 | 3/20 | 0.44 |
| ▸ | SNCA | P37840 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7765548 | 0.95 | NOX1 (0.65) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL2139511 | 0.86 | NOX1 (0.49) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL29674392 | 0.86 | NOX1 (0.49) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL885158 | 0.85 | NOX1 (0.57) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL25898787 | 0.79 | NOX1 (0.71) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL26433748 | 0.75 | NOX1 (0.46) | NOX1CYBBNOX3NOX4BCHE | |
| Benzene SCHEMBL29242186 | 0.75 | NOX1 (0.97) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL28110666 | 0.74 | NOX1 (0.58) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL9671163 | 0.73 | NOX1 (0.61) | NOX1CYBBNOX3NOX4BCHE | |
| SCHEMBL560225 | 0.72 | NOX1 (1.00) | NOX1CYBBNOX3NOX4BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0522709-B1 | Polymerization inhibitors for acrylic acids and esters | UNIROYAL CHEM CO INC (US) | 1996-08-21 | — | — | EP | claimed |
| US-4915873-A | PHENOTHIAZINE AND ARYL-SUBSTITUTED PHENYLENEDIAMINE | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1990-04-10 | — | — | US | claimed |
| EP-0334500-A1 | Vinyl aromatic compositons stabilized against polymerization | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1989-09-27 | — | — | EP | claimed |
| EP-0325059-A2 | Polymerization inhibitor composition for vinyl aromatic compounds | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1989-07-26 | — | — | EP | claimed |
| EP-3310819-B1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-10301252-B2 | Production of tert-butyl esters of ethylenically unsaturated carboxylic acids | BASF SE (DE) | 2019-05-28 | — | — | US | disclosed |
| EP-3277657-B1 | PRODUCTION OF TERT-BUTYL ESTERS OF ALIPHATIC CARBOXYLIC ACIDS | BASF SE (DE) | 2019-05-15 | — | — | EP | disclosed |
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20190002389-A1 | PRODUCTION OF TERT-BUTYL ESTERS OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2019-01-03 | — | — | US | disclosed |
| EP-3390339-A1 | PRODUCTION OF TERT-BUTYL ESTERS OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2018-10-24 | — | — | EP | disclosed |
| US-10023520-B2 | Preparation of tert-butyl esters of aliphatic carboxylic acids | BASF SE (DE) | 2018-07-17 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| EP-3277657-A1 | PRODUCTION OF TERT-BUTYL ESTERS OF ALIPHATIC CARBOXYLIC ACIDS | BASF SE (DE) | 2018-02-07 | — | — | EP | disclosed |
| WO-2017102297-A1 | PRODUCTION OF TERT-BUTYL ESTERS OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2017-06-22 | — | — | WO | disclosed |
| WO-2016202883-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2016-12-22 | — | — | WO | disclosed |
| WO-2016156410-A1 | PRODUCTION OF TERT-BUTYL ESTERS OF ALIPHATIC CARBOXYLIC ACIDS | BASF SE (DE) | 2016-10-06 | — | — | WO | disclosed |
| US-20160289159-A1 | PREPARATION OF TERT-BUTYL ESTERS OF ALIPHATIC CARBOXYLIC ACIDS | BASF SE (DE) | 2016-10-06 | — | — | US | disclosed |
| US-4915873-A | PHENOTHIAZINE AND ARYL-SUBSTITUTED PHENYLENEDIAMINE | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1990-04-10 | — | — | US | disclosed |
| EP-0334500-A1 | Vinyl aromatic compositons stabilized against polymerization | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1989-09-27 | — | — | EP | disclosed |
| EP-0325059-A2 | Polymerization inhibitor composition for vinyl aromatic compounds | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1989-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | FASTKD5, TYK2, FASTKD1 | NOX1 124/4885CYBB 63/4885NOX3 225/4885 |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | FASTKD5, TYK2, FASTKD1 | NOX1 124/4885CYBB 63/4885NOX3 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.